Asia
IndiaIndia Reduces Profit Margins on Cancer Drugs
The Indian central government has reduced profit margins on 137 cancer drugs to make treatment more accessible and affordable.
Background
India faces ongoing challenges in healthcare accessibility and affordability for its large population. The government frequently intervenes in pharmaceutical pricing to balance industry interests with public health needs, particularly for critical medications like cancer drugs.
Quorum · collective opinions
Central Government Reduces Profit Margins on Cancer Drugs
First report 4h agoLast update 4h ago1 takes 1
facilitate treatmentneutralShow 1 post
started 4h ago•Last update 4h ago
The government's action to reduce profit margins on cancer drugs is seen as a measure to make treatment easier.
iWitness comments
No comments yet — be the first to weigh in.